Skip to main content

Drug Manufacturers - Specialty & Generic

Healthcare

29 US-listed companies tracked

Specialty and generic drug manufacturers develop, produce, and market medications across therapeutic areas, competing on efficacy, cost, and regulatory approval timelines. Key drivers include patent expirations (which trigger generic competition and revenue cliffs), FDA approvals and pipeline success, pricing power influenced by healthcare policy, and input cost volatility in active pharmaceutical ingredients. TrendMatrix ranks 29 US-listed Drug Manufacturers - Specialty & Generic stocks by 10-dimension quantitative score, refreshed every 5 minutes during market hours with a full reanalysis nightly.

Sort:By verdict tierBy scoreBUY tier first, then score within

Ranked stocks

Drug Manufacturers - Specialty & Generic stocks ranked by TrendMatrix score
#SymbolScoreVerdictPriceUpside
BUY (Strong Buy Now + Strong Buy Wait)
1BCRX6.6Buy Wait$8.99+108.5%
2AMRX5.8Buy Wait$12.85+20.3%
HOLD / WATCH
3NBIX6.8Hold$132.65+27.3%
4ANIP6.4Hold$79.29+23.4%
5HIMS4.7Hold$26.52+18.6%
6PCRX4.7Hold$25.24+1.9%
SELL
7INDV6.7Sell$37.00+22.7%
8COLL6.4Sell$34.10+39.6%
9KNSA6.2Sell$53.45+2.6%
10BHC6.1Sell$6.04+17.9%
11HROW5.9Sell$40.67+47.3%
12ALVO5.8Sell$3.32+16.4%
13LNTH5.8Sell$81.25+1.3%
14PAHC5.8Sell$52.96+12.2%
15TEVA5.8Sell$35.70-1.3%
16VTRS5.6Sell$15.02-0.4%
17ZTS5.6Sell$114.06+18.3%
18HLN5.5Sell$9.30+10.5%
19SUPN5.5Sell$48.97+12.3%
20UTHR5.5Sell$569.01+2.4%
21ELAN5.3Sell$21.96+14.0%
22PRGO5.3Sell$11.40+28.0%
23AMLX5.0Sell$15.75+29.9%
24RDY5.0Sell$13.77+1.4%
25TAK5.0Sell$16.66+5.8%
26PBH4.8Sell$54.93+21.9%
27LQDA4.5Sell$38.24+15.5%
28ALKS4.4Sell$34.24+18.1%
29HCM4.4Sell$13.37+54.0%

Related Industries

Last updated 4/25/2026 · 29 stocks tracked · Methodology